THAT STIFFNESS THAT GREETS YOU EVERY MORNING.

THAT STIFFNESS THAT GREETS YOU EVERY MORNING.

Hemp, preserved close to how it grows, nourishes the body's own path back to ease. That's CBDA, and it's what most hemp products lose before they reach you.

SEE HOW IT WORKS →
100-DAY MONEY-BACK GUARANTEE

100-DAY MONEY-BACK GUARANTEE

Full refund, no questions asked, no return required

THIRD-PARTY LAB TESTED

THIRD-PARTY LAB TESTED

Every batch tested for potency, purity, and contaminants

FREE SHIPPING OVER $70

FREE SHIPPING OVER $70

Ships in 2 business days

FOUNDED BY A PhD AND MD

FOUNDED BY A PhD AND MD

Formulated by Dr. Luigi Bertoli (MD) and Dr. Colin Reily (PhD)

AS SEEN IN

You already know this feeling.

It's not dramatic. It's not an injury. It's the kind of thing that builds quietly — that moment of hesitation before you get up from the couch. Knuckles that feel stiff for the first hour. A knee that aches when it rains. Most people in their 50s and 60s accept this as just getting older. But what's actually happening underneath is an inflammatory process — and it's one that tends to go unaddressed, partly because the things we reach for either don't work well enough or come with their own problems.

Ibuprofen

Ibuprofen

Works short-term

Kidney and stomach risk

CBD Oils or Topicals

CBD Oils or Topicals

Little absorption

Little effect

Fish Oil & Turmeric

Fish Oil & Turmeric

Good baseline habits

Don't inhibit COX-2 directly

Why regular CBD probably didn't do much.

✕

Standard CBD

Produced by heating hemp — which destroys the natural CBDA. Absorbed weakly by the body. No meaningful COX-2 inhibition documented. Works mostly at the receptor level.

✓

Natural Dos CBDA

Preserved through low-temperature purification — CBDA stays intact. Absorbed 500%+ more effectively than CBD. Directly inhibits COX-2 — the enzyme driving inflammatory pain. Works at the enzyme, receptor, and nerve level simultaneously.

What's actually happening in your body.

Interrupts inflammation at the source

Interrupts inflammation at the source

CBDA directly inhibits COX-2 — the enzyme your body uses to manufacture inflammatory prostaglandins. Unlike ibuprofen, it does this selectively, targeting the inflammatory pathway while leaving the stomach-protective COX-1 pathway mostly alone.

Quiets the pain signal at the nerve

Quiets the pain signal at the nerve

CBDA acts on TRPV1 — the ion channel on sensory nerves that acts as the "pain gate." Chronic inflammation keeps this gate stuck open. CBDA gradually desensitizes it, raising the threshold back toward normal. This is why the effect tends to build over time.

Reduces immune-driven inflammation

Reduces immune-driven inflammation

CBDA suppresses pro-inflammatory cytokines — specifically TNF-α and IL-6 — that keep the inflammatory cycle running. This deeper mechanism makes CBDA relevant not just for comfort but for reducing the ongoing immune activity that contributes to joint tissue breakdown.

WHAT CUSTOMERS ARE SAYING

REAL RESULTS FROM REAL PEOPLE.

★★★★★
I'd been taking ibuprofen pretty much every day for my knees for about three years. My doctor kept telling me to cut back. I tried CBD twice before — drops and gummies — and honestly felt nothing. My daughter found Natural Dos and convinced me to try it. After about three weeks I realized I hadn't reached for the ibuprofen in a while. That was the tell for me. Still not pain-free, but it's manageable in a way it wasn't before.
ROBERT M., 67 · Verified Customer
★★★★★
I was skeptical because I know enough about pharmacology to be skeptical of most supplements. But the COX-2 mechanism made sense to me. I've been taking the softgels for two months and my hands are noticeably less stiff in the mornings. That used to be the worst part of my day. It's not magic, but it's real and consistent.
MARGARET D., 59 · Verified Customer
★★★★☆
Knees and lower back, both been a problem for years. Physical work will do that. I started with the gummies and switched to the softgels after reading the absorption info. The softgels are better for me. Takes a few weeks to kick in but once it does, the difference in how I move in the morning is noticeable. My wife says I stop complaining less.
GARY T., 64 · Verified Customer
★★★★★ ★★★★★
MOVE EASIER AGAIN →

Scientific References

NaturalDos™ is not endorsed by, sponsored by, or affiliated with any of these organizations.

ACS Chemistry for Life
British Pharmacological Society
PAIN Journal
Springer
Scientific Reports
Nature Portfolio
1. Formato, M. et al. (2020). Cannabidiolic-Acid (CBDA): A Unique Compound of Cannabis. Molecules, 25(21), 4936.
2. Bolognini, D. et al. (2013). Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. British Journal of Pharmacology, 168(6), 1456–1470.
3. Rock, E.M. et al. (2020). Cannabidiol and cannabidiolic acid reduce nausea and vomiting. Cannabis and Cannabinoid Research, 5(3), 191–198.
4. Takeda, S. et al. (2008). Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis. Drug Metabolism and Disposition, 36(9), 1917–1921.
5. Rock, E.M. et al. (2018). Effect of cannabidiolic acid and ∆9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema. Psychopharmacology, 235, 3259–3271.
6. Anderson, L.L. et al. (2019). Pharmacokinetics of phytocannabinoid acids and anticonvulsant effect of cannabidiolic acid in a mouse model of Dravet Syndrome. Journal of Natural Products, 82(11), 3047–3055.
7. Pertwee, R.G. et al. (2018). Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT1A receptor-mediated suppression of nausea. British Journal of Pharmacology, 175(1), 100–112.
8. Zhu, H.J. et al. (2006). Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana. Journal of Pharmacology and Experimental Therapeutics, 317(3), 850–857.
9. Pellesi, L. et al. (2018). European Journal of Clinical Pharmacology: Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache.
10. Ujváry, I. & Hanuš, L. (2016). Human metabolites of cannabidiol: A review on their formation, biological activity, and relevance in therapy. Cannabis and Cannabinoid Research, 1(1), 90–101.
11. Rock, E.M. & Parker, L.A. (2013). Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping in rats. British Journal of Pharmacology, 169(3), 685–692.
12. Takeda, S. et al. (2014). Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells. Journal of Toxicological Sciences, 39(5), 711–716.
13. De Petrocellis, L. et al. (2011). Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. British Journal of Pharmacology, 163(7), 1479–1494.
14. Navarro, G. et al. (2020). Cannabigerol action at cannabinoid CB1 and CB2 receptors and CB1–CB2 heteroreceptor complexes. Frontiers in Pharmacology, 11, 422.
15. Shannon, S. et al. (2019). Cannabidiol in anxiety and sleep: A large case series. The Permanente Journal, 23, 18–041.
16. Suraev, A.S. et al. (2020). Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies. Sleep Medicine Reviews, 53, 101339.
17. Kesner, A.J. & Lovinger, D.M. (2020). Cannabinoids, endocannabinoids and sleep. Frontiers in Molecular Neuroscience, 13, 125.
18. Murillo-Rodriguez, E. et al. (2006). Anandamide modulates sleep and memory in rats. Brain Research, 1075(1), 108–115.
19. Pacher, P. et al. (2006). The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacological Reviews, 58(3), 389–462.
20. Russo, E.B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364.